Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001193125-26-102469 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 11, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
688,788
Total Value
$13,149,313.71
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 9, 2026 | Sale | 177,690 | $17.72 | $3,148,986.64 | 5,285,156 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Mar 10, 2026 | Sale | 9,482 | $18.21 | $172,687.13 | 5,275,674 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Mar 10, 2026 | Sale | 219,758 | $19.32 | $4,246,823.35 | 5,055,916 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Mar 10, 2026 | Sale | 281,858 | $19.80 | $5,580,816.59 | 4,774,058 | Indirect | See footnote | View Details |